Mereo BioPharma Group plc
MREO
$2.17
-$0.08-3.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 500.00K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 500.00K | -- | -- | -- |
| Cost of Revenue | -- | 132.00K | -- | -- | -- |
| Gross Profit | -- | 368.00K | -- | -- | -- |
| SG&A Expenses | 6.05M | 5.49M | 7.27M | 6.45M | 6.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.87M | 10.25M | 11.02M | 14.70M | 9.15M |
| Operating Income | -9.87M | -9.75M | -11.02M | -14.70M | -9.15M |
| Income Before Tax | -7.02M | -14.62M | -12.89M | -7.05M | -15.00M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.02M | -14.62M | -12.89M | -7.05M | -15.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.02M | -14.62M | -12.89M | -7.05M | -15.00M |
| EBIT | -9.87M | -9.75M | -11.02M | -14.70M | -9.15M |
| EBITDA | -9.82M | -9.59M | -10.87M | -14.55M | -8.99M |
| EPS Basic | -0.22 | -0.46 | -0.41 | -0.23 | -0.49 |
| Normalized Basic EPS | -0.03 | -0.06 | -0.05 | -0.03 | -0.06 |
| EPS Diluted | -0.22 | -0.46 | -0.41 | -0.23 | -0.49 |
| Normalized Diluted EPS | -0.03 | -0.06 | -0.05 | -0.03 | -0.06 |
| Average Basic Shares Outstanding | 159.99M | 159.89M | 156.86M | 155.01M | 154.03M |
| Average Diluted Shares Outstanding | 32.00M | 31.98M | 31.37M | 31.00M | 30.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |